Gary D. Hammer - Publications

Affiliations: 
University of Michigan, Ann Arbor, Ann Arbor, MI 
Area:
Molecular Biology, Cell Biology, Animal Physiology Biology

78 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Gharzai LA, Green MD, Griffith KA, Else T, Mayo CS, Hesseltine E, Spratt DE, Ben-Josef E, Sabolch A, Miller BS, Worden F, Giordano TJ, Hammer GD, Jolly S. Adjuvant Radiation Improves Recurrence-Free Survival and Overall Survival in Adrenocortical Carcinoma. The Journal of Clinical Endocrinology and Metabolism. PMID 31220287 DOI: 10.1210/jc.2019-00029  0.32
2019 Mohan DR, Lerario AM, Else T, Mukherjee B, Almeida MQ, Vinco M, Rege J, Mariani BMP, Zerbini MCN, Mendonca BB, Latronico AC, Marie SKN, Rainey WE, Giordano TJ, Fragoso MCBV, ... Hammer GD, et al. Targeted assessment of methylation identifies a rapidly recurrent, routinely fatal molecular subtype of adrenocortical carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30770352 DOI: 10.1158/1078-0432.CCR-18-2693  0.32
2018 Glenn JA, Else T, Hughes DT, Cohen MS, Jolly S, Giordano TJ, Worden FP, Gauger PG, Hammer GD, Miller BS. Longitudinal patterns of recurrence in patients with adrenocortical carcinoma. Surgery. PMID 30343951 DOI: 10.1016/j.surg.2018.04.068  0.32
2017 Else T, Marcondes Lerario A, Everett J, Haymon L, Wham D, Mullane M, Wilson TL, Rainville I, Rana H, Worth AJ, Snyder NW, Blair IA, McKay R, Kilbridge K, Hammer GD, et al. Adrenocortical carcinoma and succinate dehydrogenase gene mutations. European Journal of Endocrinology. PMID 28819017 DOI: 10.1530/EJE-17-0358  0.32
2016 Zheng S, Cherniack AD, Dewal N, Moffitt RA, Danilova L, Murray BA, Lerario AM, Else T, Knijnenburg TA, Ciriello G, Kim S, Assie G, Morozova O, Akbani R, Shih J, ... ... Hammer GD, et al. Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell. 30: 363. PMID 27505681 DOI: 10.1016/j.ccell.2016.07.013  0.48
2016 Nanba K, Omata K, Tomlins SA, Giordano TJ, Hammer G, Rainey WE, Else T. Double adrenocortical adenomas harboring independent KCNJ5 and PRKACA somatic mutations. European Journal of Endocrinology / European Federation of Endocrine Societies. PMID 27165862 DOI: 10.1530/EJE-16-0262  0.88
2016 Zheng S, Cherniack AD, Dewal N, Moffitt RA, Danilova L, Murray BA, Lerario AM, Else T, Knijnenburg TA, Ciriello G, Kim S, Assie G, Morozova O, Akbani R, Shih J, ... ... Hammer GD, et al. Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell. 29: 723-36. PMID 27165744 DOI: 10.1016/j.ccell.2016.04.002  0.88
2016 Nanba K, Chen AX, Omata K, Vinco M, Giordano TJ, Else T, Hammer GD, Tomlins SA, Rainey WE. Molecular Heterogeneity in Aldosterone-Producing Adenomas. The Journal of Clinical Endocrinology and Metabolism. jc20153239. PMID 26765578 DOI: 10.1210/jc.2015-3239  0.88
2016 Lee J, Yang DJ, Lee S, Hammer GD, Kim KW, Elmquist JK. Nutritional conditions regulate transcriptional activity of SF-1 by controlling sumoylation and ubiquitination. Scientific Reports. 6: 19143. PMID 26750456 DOI: 10.1038/srep19143  0.88
2015 Xing Y, Lerario AM, Rainey W, Hammer GD. Development of adrenal cortex zonation. Endocrinology and Metabolism Clinics of North America. 44: 243-74. PMID 26038200 DOI: 10.1016/j.ecl.2015.02.001  0.88
2015 Fassnacht M, Berruti A, Baudin E, Demeure MJ, Gilbert J, Haak H, Kroiss M, Quinn DI, Hesseltine E, Ronchi CL, Terzolo M, Choueiri TK, Poondru S, Fleege T, Rorig R, ... ... Hammer GD, et al. Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study. The Lancet. Oncology. 16: 426-35. PMID 25795408 DOI: 10.1016/S1470-2045(15)70081-1  0.88
2015 Sabolch A, Else T, Griffith KA, Ben-Josef E, Williams A, Miller BS, Worden F, Hammer GD, Jolly S. Adjuvant radiation therapy improves local control after surgical resection in patients with localized adrenocortical carcinoma. International Journal of Radiation Oncology, Biology, Physics. 92: 252-9. PMID 25754631 DOI: 10.1016/j.ijrobp.2015.01.007  0.88
2015 Finco I, LaPensee CR, Krill KT, Hammer GD. Hedgehog signaling and steroidogenesis. Annual Review of Physiology. 77: 105-29. PMID 25668018 DOI: 10.1146/annurev-physiol-061214-111754  0.88
2015 Walczak EM, Hammer GD. Regulation of the adrenocortical stem cell niche: implications for disease. Nature Reviews. Endocrinology. 11: 14-28. PMID 25287283 DOI: 10.1038/nrendo.2014.166  0.88
2014 Walczak EM, Kuick R, Finco I, Bohin N, Hrycaj SM, Wellik DM, Hammer GD. Wnt signaling inhibits adrenal steroidogenesis by cell-autonomous and non-cell-autonomous mechanisms. Molecular Endocrinology (Baltimore, Md.). 28: 1471-86. PMID 25029241 DOI: 10.1210/me.2014-1060  0.88
2014 Lerario AM, Worden FP, Ramm CA, Hesseltine EA, Hasseltine EA, Stadler WM, Else T, Shah MH, Agamah E, Rao K, Hammer GD. The combination of insulin-like growth factor receptor 1 (IGF1R) antibody cixutumumab and mitotane as a first-line therapy for patients with recurrent/metastatic adrenocortical carcinoma: a multi-institutional NCI-sponsored trial. Hormones & Cancer. 5: 232-9. PMID 24849545 DOI: 10.1007/s12672-014-0182-1  0.88
2014 Williams AR, Hammer GD, Else T. Transcutaneous biopsy of adrenocortical carcinoma is rarely helpful in diagnosis, potentially harmful, but does not affect patient outcome. European Journal of Endocrinology / European Federation of Endocrine Societies. 170: 829-35. PMID 24836548 DOI: 10.1530/EJE-13-1033  0.88
2014 Auchus RJ, Buschur EO, Chang AY, Hammer GD, Ramm C, Madrigal D, Wang G, Gonzalez M, Xu XS, Smit JW, Jiao J, Yu MK. Abiraterone acetate to lower androgens in women with classic 21-hydroxylase deficiency. The Journal of Clinical Endocrinology and Metabolism. 99: 2763-70. PMID 24780050 DOI: 10.1210/jc.2014-1258  0.88
2014 Else T, Kim AC, Sabolch A, Raymond VM, Kandathil A, Caoili EM, Jolly S, Miller BS, Giordano TJ, Hammer GD. Adrenocortical carcinoma. Endocrine Reviews. 35: 282-326. PMID 24423978 DOI: 10.1210/er.2013-1029  0.88
2014 Else T, Williams AR, Sabolch A, Jolly S, Miller BS, Hammer GD. Adjuvant therapies and patient and tumor characteristics associated with survival of adult patients with adrenocortical carcinoma. The Journal of Clinical Endocrinology and Metabolism. 99: 455-61. PMID 24302750 DOI: 10.1210/jc.2013-2856  0.88
2014 Berruti A, Fassnacht M, Haak H, Else T, Baudin E, Sperone P, Kroiss M, Kerkhofs T, Williams AR, Ardito A, Leboulleux S, Volante M, Deutschbein T, Feelders R, Ronchi C, ... ... Hammer GD, et al. Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancer. European Urology. 65: 832-8. PMID 24268504 DOI: 10.1016/j.eururo.2013.11.006  0.88
2014 Lerario AM, Moraitis A, Hammer GD. Genetics and epigenetics of adrenocortical tumors. Molecular and Cellular Endocrinology. 386: 67-84. PMID 24220673 DOI: 10.1016/j.mce.2013.10.028  0.88
2014 Raymond VM, Long JM, Everett JN, Caoili EM, Gruber SB, Stoffel EM, Giordano TJ, Hammer GD, Else T. An oncocytic adrenal tumour in a patient with Birt-Hogg-Dubé syndrome. Clinical Endocrinology. 80: 925-7. PMID 23848572 DOI: 10.1111/cen.12292  0.88
2013 Wood MA, Acharya A, Finco I, Swonger JM, Elston MJ, Tallquist MD, Hammer GD. Fetal adrenal capsular cells serve as progenitor cells for steroidogenic and stromal adrenocortical cell lineages in M. musculus. Development (Cambridge, England). 140: 4522-32. PMID 24131628 DOI: 10.1242/dev.092775  0.88
2013 Raymond VM, Everett JN, Furtado LV, Gustafson SL, Jungbluth CR, Gruber SB, Hammer GD, Stoffel EM, Greenson JK, Giordano TJ, Else T. Adrenocortical carcinoma is a lynch syndrome-associated cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 3012-8. PMID 23752102 DOI: 10.1200/JCO.2012.48.0988  0.88
2013 Krill KT, Gurdziel K, Heaton JH, Simon DP, Hammer GD. Dicer deficiency reveals microRNAs predicted to control gene expression in the developing adrenal cortex. Molecular Endocrinology (Baltimore, Md.). 27: 754-68. PMID 23518926 DOI: 10.1210/me.2012-1331  0.88
2013 França MM, Ferraz-de-Souza B, Santos MG, Lerario AM, Fragoso MC, Latronico AC, Kuick RD, Hammer GD, Lotfi CF. POD-1 binding to the E-box sequence inhibits SF-1 and StAR expression in human adrenocortical tumor cells. Molecular and Cellular Endocrinology. 371: 140-7. PMID 23313103 DOI: 10.1016/j.mce.2012.12.029  0.88
2013 Raymond VM, Else T, Everett JN, Long JM, Gruber SB, Hammer GD. Prevalence of germline TP53 mutations in a prospective series of unselected patients with adrenocortical carcinoma. The Journal of Clinical Endocrinology and Metabolism. 98: E119-25. PMID 23175693 DOI: 10.1210/jc.2012-2198  0.88
2012 Miller BS, Gauger PG, Hammer GD, Doherty GM. Resection of adrenocortical carcinoma is less complete and local recurrence occurs sooner and more often after laparoscopic adrenalectomy than after open adrenalectomy. Surgery. 152: 1150-7. PMID 23158185 DOI: 10.1016/j.surg.2012.08.024  0.88
2012 Heaton JH, Wood MA, Kim AC, Lima LO, Barlaskar FM, Almeida MQ, Fragoso MC, Kuick R, Lerario AM, Simon DP, Soares IC, Starnes E, Thomas DG, Latronico AC, Giordano TJ, ... Hammer GD, et al. Progression to adrenocortical tumorigenesis in mice and humans through insulin-like growth factor 2 and β-catenin. The American Journal of Pathology. 181: 1017-33. PMID 22800756 DOI: 10.1016/j.ajpath.2012.05.026  0.88
2012 Miller BS, Ignatoski KM, Daignault S, Lindland C, Doherty M, Gauger PG, Hammer GD, Wang SC, Doherty GM. Worsening central sarcopenia and increasing intra-abdominal fat correlate with decreased survival in patients with adrenocortical carcinoma. World Journal of Surgery. 36: 1509-16. PMID 22526034 DOI: 10.1007/s00268-012-1581-5  0.88
2012 Simon DP, Giordano TJ, Hammer GD. Upregulated JAG1 enhances cell proliferation in adrenocortical carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 2452-64. PMID 22427350 DOI: 10.1158/1078-0432.CCR-11-2371  0.88
2012 Simon DP, Hammer GD. Adrenocortical stem and progenitor cells: implications for adrenocortical carcinoma. Molecular and Cellular Endocrinology. 351: 2-11. PMID 22266195 DOI: 10.1016/j.mce.2011.12.006  0.88
2012 Hammer GD, Fassnacht M, Lalli E. Adrenal cancer: scientific advances. Molecular and Cellular Endocrinology. 351: 1. PMID 22108436 DOI: 10.1016/j.mce.2011.11.010  0.88
2011 Hammer GD, Fassnacht M, Lalli E. Adrenal cancer: clinical advances. Hormones & Cancer. 2: 323. PMID 22173667 DOI: 10.1007/s12672-011-0092-4  0.88
2011 Nasonkin IO, Ward RD, Bavers DL, Beuschlein F, Mortensen AH, Keegan CE, Hammer GD, Camper SA. Aged PROP1 deficient dwarf mice maintain ACTH production. Plos One. 6: e28355. PMID 22145038 DOI: 10.1371/journal.pone.0028355  0.88
2011 Scheys JO, Heaton JH, Hammer GD. Evidence of adrenal failure in aging Dax1-deficient mice. Endocrinology. 152: 3430-9. PMID 21733829 DOI: 10.1210/en.2010-0986  0.88
2011 Dobrosotskaya IY, Hammer GD, Schteingart DE, Maturen KE, Worden FP. Mebendazole monotherapy and long-term disease control in metastatic adrenocortical carcinoma. Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 17: e59-62. PMID 21454232 DOI: 10.4158/EP10390.CR  0.88
2011 Wood MA, Hammer GD. Adrenocortical stem and progenitor cells: unifying model of two proposed origins. Molecular and Cellular Endocrinology. 336: 206-12. PMID 21094677 DOI: 10.1016/j.mce.2010.11.012  0.88
2011 Kelly VR, Hammer GD. LRH-1 and Nanog regulate Dax1 transcription in mouse embryonic stem cells. Molecular and Cellular Endocrinology. 332: 116-24. PMID 20937355 DOI: 10.1016/j.mce.2010.10.003  0.88
2010 Kelly VR, Xu B, Kuick R, Koenig RJ, Hammer GD. Dax1 up-regulates Oct4 expression in mouse embryonic stem cells via LRH-1 and SRA. Molecular Endocrinology (Baltimore, Md.). 24: 2281-91. PMID 20943815 DOI: 10.1210/me.2010-0133  0.88
2010 Miller BS, Gauger PG, Hammer GD, Giordano TJ, Doherty GM. Proposal for modification of the ENSAT staging system for adrenocortical carcinoma using tumor grade. Langenbeck's Archives of Surgery / Deutsche Gesellschaft FüR Chirurgie. 395: 955-61. PMID 20694732 DOI: 10.1007/s00423-010-0698-y  0.88
2010 Garcia-Perez JL, Morell M, Scheys JO, Kulpa DA, Morell S, Carter CC, Hammer GD, Collins KL, O'Shea KS, Menendez P, Moran JV. Epigenetic silencing of engineered L1 retrotransposition events in human embryonic carcinoma cells. Nature. 466: 769-73. PMID 20686575 DOI: 10.1038/nature09209  0.88
2010 Watson RL, Spalding AC, Zielske SP, Morgan M, Kim AC, Bommer GT, Eldar-Finkelman H, Giordano T, Fearon ER, Hammer GD, Lawrence TS, Ben-Josef E. GSK3beta and beta-catenin modulate radiation cytotoxicity in pancreatic cancer. Neoplasia (New York, N.Y.). 12: 357-65. PMID 20454507 DOI: 10.1593/neo.92112  0.88
2010 Looyenga BD, Wiater E, Vale W, Hammer GD. Inhibin-A antagonizes TGFbeta2 signaling by down-regulating cell surface expression of the TGFbeta coreceptor betaglycan. Molecular Endocrinology (Baltimore, Md.). 24: 608-20. PMID 20160125 DOI: 10.1210/me.2008-0374  0.88
2009 Else T, Trovato A, Kim AC, Wu Y, Ferguson DO, Kuick RD, Lucas PC, Hammer GD. Genetic p53 deficiency partially rescues the adrenocortical dysplasia phenotype at the expense of increased tumorigenesis. Cancer Cell. 15: 465-76. PMID 19477426 DOI: 10.1016/j.ccr.2009.04.011  0.88
2009 Kim AC, Barlaskar FM, Heaton JH, Else T, Kelly VR, Krill KT, Scheys JO, Simon DP, Trovato A, Yang WH, Hammer GD. In search of adrenocortical stem and progenitor cells. Endocrine Reviews. 30: 241-63. PMID 19403887 DOI: 10.1210/er.2008-0039  0.88
2009 Xu B, Yang WH, Gerin I, Hu CD, Hammer GD, Koenig RJ. Dax-1 and steroid receptor RNA activator (SRA) function as transcriptional coactivators for steroidogenic factor 1 in steroidogenesis. Molecular and Cellular Biology. 29: 1719-34. PMID 19188450 DOI: 10.1128/MCB.01010-08  0.88
2009 Yang WH, Heaton JH, Brevig H, Mukherjee S, Iñiguez-Lluhí JA, Hammer GD. SUMOylation inhibits SF-1 activity by reducing CDK7-mediated serine 203 phosphorylation. Molecular and Cellular Biology. 29: 613-25. PMID 19015234 DOI: 10.1128/MCB.00295-08  0.88
2009 Barlaskar FM, Spalding AC, Heaton JH, Kuick R, Kim AC, Thomas DG, Giordano TJ, Ben-Josef E, Hammer GD. Preclinical targeting of the type I insulin-like growth factor receptor in adrenocortical carcinoma. The Journal of Clinical Endocrinology and Metabolism. 94: 204-12. PMID 18854392 DOI: 10.1210/jc.2008-1456  0.88
2008 Kim AC, Reuter AL, Zubair M, Else T, Serecky K, Bingham NC, Lavery GG, Parker KL, Hammer GD. Targeted disruption of beta-catenin in Sf1-expressing cells impairs development and maintenance of the adrenal cortex. Development (Cambridge, England). 135: 2593-602. PMID 18599507 DOI: 10.1242/dev.021493  0.88
2008 Rui X, Tsao J, Scheys JO, Hammer GD, Schimmer BP. Contributions of specificity protein-1 and steroidogenic factor 1 to Adcy4 expression in Y1 mouse adrenal cells. Endocrinology. 149: 3668-78. PMID 18388192 DOI: 10.1210/en.2008-0203  1
2008 Else T, Giordano TJ, Hammer GD. Evaluation of telomere length maintenance mechanisms in adrenocortical carcinoma. The Journal of Clinical Endocrinology and Metabolism. 93: 1442-9. PMID 18198226 DOI: 10.1210/jc.2007-1840  0.32
2007 Else T, Theisen BK, Wu Y, Hutz JE, Keegan CE, Hammer GD, Ferguson DO. Tpp1/Acd maintains genomic stability through a complex role in telomere protection Chromosome Research. 15: 1001-1013. PMID 18185984 DOI: 10.1007/s10577-007-1175-5  0.88
2007 Barlaskar FM, Hammer GD. The molecular genetics of adrenocortical carcinoma. Reviews in Endocrine & Metabolic Disorders. 8: 343-8. PMID 17934868 DOI: 10.1007/s11154-007-9057-x  1
2007 Looyenga BD, Hammer GD. Genetic removal of Smad3 from inhibin-null mice attenuates tumor progression by uncoupling extracellular mitogenic signals from the cell cycle machinery. Molecular Endocrinology (Baltimore, Md.). 21: 2440-57. PMID 17652186 DOI: 10.1210/me.2006-0402  0.96
2007 Hockemeyer D, Palm W, Else T, Daniels JP, Takai KK, Ye JZ, Keegan CE, de Lange T, Hammer GD. Telomere protection by mammalian Pot1 requires interaction with Tpp1. Nature Structural & Molecular Biology. 14: 754-61. PMID 17632522 DOI: 10.1038/nsmb1270  0.88
2007 Keegan CE, Hutz JE, Krause AS, Koehler K, Metherell LA, Boikos S, Stergiopoulos S, Clark AJL, Stratakis CA, Huebner A, Hammer GD. Novel polymorphisms and lack of mutations in the ACD gene in patients with ACTH resistance syndromes Clinical Endocrinology. 67: 168-174. PMID 17466001 DOI: 10.1111/j.1365-2265.2007.02855.x  0.88
2007 Kim AC, Hammer GD. Adrenocortical cells with stem/progenitor cell properties: recent advances. Molecular and Cellular Endocrinology. 265: 10-6. PMID 17240045 DOI: 10.1016/j.mce.2006.12.028  0.88
2007 Lichtenauer UD, Duchniewicz M, Kolanczyk M, Hoeflich A, Hahner S, Else T, Bicknell AB, Zemojtel T, Stallings NR, Schulte DM, Kamps MP, Hammer GD, Scheele JS, Beuschlein F. Pre-B-cell transcription factor 1 and steroidogenic factor 1 synergistically regulate adrenocortical growth and steroidogenesis. Endocrinology. 148: 693-704. PMID 17082260 DOI: 10.1210/en.2006-0681  0.88
2006 Looyenga BD, Hammer GD. Origin and identity of adrenocortical tumors in inhibin knockout mice: implications for cellular plasticity in the adrenal cortex. Molecular Endocrinology (Baltimore, Md.). 20: 2848-63. PMID 16873442 DOI: 10.1210/me.2006-0182  0.96
2006 Gummow BM, Scheys JO, Cancelli VR, Hammer GD. Reciprocal regulation of a glucocorticoid receptor-steroidogenic factor-1 transcription complex on the Dax-1 promoter by glucocorticoids and adrenocorticotropic hormone in the adrenal cortex. Molecular Endocrinology (Baltimore, Md.). 20: 2711-23. PMID 16857744 DOI: 10.1210/me.2005-0461  1
2006 Johnsen IK, Slawik M, Shapiro I, Hartmann MF, Wudy SA, Looyenga BD, Hammer GD, Reincke M, Beuschlein F. Gonadectomy in mice of the inbred strain CE/J induces proliferation of sub-capsular adrenal cells expressing gonadal marker genes. The Journal of Endocrinology. 190: 47-57. PMID 16837610 DOI: 10.1677/joe.1.06750  0.96
2006 Hutz JE, Krause AS, Achermann JC, Vilain E, Tauber M, Lecointre C, McCabe ER, Hammer GD, Keegan CE. IMAGe association and congenital adrenal hypoplasia: no disease-causing mutations found in the ACD gene. Molecular Genetics and Metabolism. 88: 66-70. PMID 16504561 DOI: 10.1016/j.ymgme.2006.01.006  0.88
2006 Winnay JN, Xu J, O'Malley BW, Hammer GD. Steroid receptor coactivator-1-deficient mice exhibit altered hypothalamic-pituitary-adrenal axis function. Endocrinology. 147: 1322-32. PMID 16339206 DOI: 10.1210/en.2005-0751  0.88
2006 Winnay JN, Hammer GD. Adrenocorticotropic hormone-mediated signaling cascades coordinate a cyclic pattern of steroidogenic factor 1-dependent transcriptional activation. Molecular Endocrinology (Baltimore, Md.). 20: 147-66. PMID 16109736 DOI: 10.1210/me.2005-0215  0.88
2005 Else T, Hammer GD. Genetic analysis of adrenal absence: agenesis and aplasia. Trends in Endocrinology and Metabolism: Tem. 16: 458-68. PMID 16275119 DOI: 10.1016/j.tem.2005.10.004  0.32
2005 Hammer GD, Parker KL, Schimmer BP. Minireview: transcriptional regulation of adrenocortical development. Endocrinology. 146: 1018-24. PMID 15604207 DOI: 10.1210/en.2004-1385  0.88
2005 Keegan CE, Hutz JE, Else T, Adamska M, Shah SP, Kent AE, Howes JM, Beamer WG, Hammer GD. Urogenital and caudal dysgenesis in adrenocortical dysplasia (acd) mice is caused by a splicing mutation in a novel telomeric regulator. Human Molecular Genetics. 14: 113-23. PMID 15537664 DOI: 10.1093/hmg/ddi011  0.32
2004 Looyenga B, Beuschlein F, Nilson J, Hammer GD. Mechanistic roles of inhibin as a tumor suppressor in the adrenal cortex Endocrine Research. 30: 585-586. PMID 15666795 DOI: 10.1081/ERC-200043745  0.88
2004 Hammer GD, Tyrrell JB, Lamborn KR, Applebury CB, Hannegan ET, Bell S, Rahl R, Lu A, Wilson CB. Transsphenoidal microsurgery for Cushing's disease: initial outcome and long-term results. The Journal of Clinical Endocrinology and Metabolism. 89: 6348-57. PMID 15579802 DOI: 10.1210/jc.2003-032180  0.88
2004 Beuschlein F, Looyenga BD, Reincke M, Hammer GD. Role of the inhibin/activin system and luteinizing hormone in adrenocortical tumorigenesis. Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et MéTabolisme. 36: 392-6. PMID 15241730 DOI: 10.1055/s-2004-814584  0.96
2003 Kennell JA, O'Leary EE, Gummow BM, Hammer GD, MacDougald OA. T-cell factor 4N (TCF-4N), a novel isoform of mouse TCF-4, synergizes with beta-catenin to coactivate C/EBPalpha and steroidogenic factor 1 transcription factors. Molecular and Cellular Biology. 23: 5366-75. PMID 12861022  1
2003 Beuschlein F, Looyenga BD, Bleasdale SE, Mutch C, Bavers DL, Parlow AF, Nilson JH, Hammer GD. Activin induces x-zone apoptosis that inhibits luteinizing hormone-dependent adrenocortical tumor formation in inhibin-deficient mice. Molecular and Cellular Biology. 23: 3951-64. PMID 12748296 DOI: 10.1128/MCB.23.11.3951-3964.2003  0.88
2003 Gummow BM, Winnay JN, Hammer GD. Convergence of Wnt signaling and steroidogenic factor-1 (SF-1) on transcription of the rat inhibin alpha gene. The Journal of Biological Chemistry. 278: 26572-9. PMID 12732619 DOI: 10.1074/jbc.M212677200  1
2002 Beuschlein F, Mutch C, Bavers DL, Ulrich-Lai YM, Engeland WC, Keegan C, Hammer GD. Steroidogenic factor-1 is essential for compensatory adrenal growth following unilateral adrenalectomy. Endocrinology. 143: 3122-35. PMID 12130578 DOI: 10.1210/endo.143.8.8944  0.88
2002 Beuschlein F, Hammer GD. Ectopic pro-opiomelanocortin syndrome. Endocrinology and Metabolism Clinics of North America. 31: 191-234. PMID 12055989  0.48
2002 Babu PS, Bavers DL, Beuschlein F, Shah S, Jeffs B, Jameson JL, Hammer GD. Interaction between Dax-1 and steroidogenic factor-1 in vivo: increased adrenal responsiveness to ACTH in the absence of Dax-1. Endocrinology. 143: 665-73. PMID 11796523 DOI: 10.1210/endo.143.2.8658  0.48
Show low-probability matches.